Clinical Trial Update: Post-Market Study of the EPIK Knee System

View source ↗

Summary

A post-market study of the EPIK Knee System sponsored by Encore Medical, L.P. has been withdrawn. The study addressed osteoarthritis and post-traumatic osteoart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Post-traumatic Osteoarthritis

Drugs mentioned

• EPIK Knee System

Snippet

Sponsor: Encore Medical, L.P. | Conditions: Osteoarthritis, Post Traumatic Degenerative Disease | Status: WITHDRAWN